According to Yiming Pharmaceutical's announcement, shareholders holding 5% or more of their shares, Zhou Zhan reduced their holdings of 1,241,100 shares and 658,900 shares respectively through bulk transactions on July 30 and August 11, 2026, reducing their holdings by a total of 1,900,000 shares, accounting for 0.996% of the total share capital. After this reduction in holdings, its holdings fell to 8,874,925 shares, accounting for 4.6544% of the total share capital. The holdings reduction plan complies with regulations, does not violate promises, and will not cause changes in control or affect the company's operations.

According to Yiming Pharmaceutical's announcement, shareholders holding 5% or more of their shares, Zhou Zhan reduced their holdings of 1,241,100 shares and 658,900 shares respectively through bulk transactions on July 30 and August 11, 2026, reducing their holdings by a total of 1,900,000 shares, accounting for 0.996% of the total share capital. After this reduction in holdings, its holdings fell to 8,874,925 shares, accounting for 4.6544% of the total share capital. The holdings reduction plan complies with regulations, does not violate promises, and will not cause changes in control or affect the company's operations.